Literature DB >> 20153798

Adverse health effects of anabolic-androgenic steroids.

Jan van Amsterdam1, Antoon Opperhuizen, Fred Hartgens.   

Abstract

Anabolic-androgenic steroids (AAS) are synthetic drugs derived from testosterone. Illegally, these drugs are regularly self-administered by body builders and power lifters to enhance their sportive performance. Adverse side effects of AAS include sexual dysfunction, alterations of the cardiovascular system, psyche and behavior, and liver toxicity. However, severe side effects appear only following prolonged use of AAS at high dose and their occurrence is limited. Occasionally, AAS abuse may be linked to certain social and psychological traits of the user, like low self-esteem, low self-confidence, suffered hostility, childhood conduct disorder, and tendency to high-risk behavior. The overwhelming stereotype about AAS is that these compounds cause aggressive behavior in males. However, the underlying personality traits of a specific subgroup of the AAS abusers, who show aggression and hostility, may be relevant, as well. Use of AAS in combination with alcohol largely increases the risk of violence and aggression. The dependence liability of AAS is very low, and withdrawal effects are relatively mild. Based on the scores for acute and chronic adverse health effects, the prevalence of use, social harm and criminality, AAS were ranked among 19 illicit drugs as a group of drugs with a relatively low harm. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153798     DOI: 10.1016/j.yrtph.2010.02.001

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  36 in total

1.  Effectiveness of Anabolic Steroid Preventative Intervention among Gym Users: Applying Theory of Planned Behavior.

Authors:  Farzad Jalilian; Hamid Allahverdipour; Babak Moeini; Abbas Moghimbeigi
Journal:  Health Promot Perspect       Date:  2011-07-25

2.  Sport nutrition and doping in tennis: an analysis of athletes' attitudes and knowledge.

Authors:  Miran Kondric; Damir Sekulic; Ognjen Uljevic; Goran Gabrilo; Milan Zvan
Journal:  J Sports Sci Med       Date:  2013-06-01       Impact factor: 2.988

3.  Computational Assessment of Pharmacokinetics and Biological Effects of Some Anabolic and Androgen Steroids.

Authors:  Marin Roman; Diana Larisa Roman; Vasile Ostafe; Alecu Ciorsac; Adriana Isvoran
Journal:  Pharm Res       Date:  2018-02-05       Impact factor: 4.200

Review 4.  Testosterone and sport: current perspectives.

Authors:  Ruth I Wood; Steven J Stanton
Journal:  Horm Behav       Date:  2011-10-01       Impact factor: 3.587

5.  Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach.

Authors:  Miran Kondric; Damir Sekulic; Andrea Petroczi; Ljerka Ostojic; Jelena Rodek; Zdenko Ostojic
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-10-11

Review 6.  Prevalence of doping use in elite sports: a review of numbers and methods.

Authors:  Olivier de Hon; Harm Kuipers; Maarten van Bottenburg
Journal:  Sports Med       Date:  2015-01       Impact factor: 11.136

Review 7.  Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health.

Authors:  Christopher Wu; Jason R Kovac
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

8.  Anabolic-androgenic steroids and cognitive effort discounting in male rats.

Authors:  Lisa B Dokovna; Grace Li; Ruth I Wood
Journal:  Horm Behav       Date:  2019-05-08       Impact factor: 3.587

9.  Stevens-Johnson syndrome and abuse of anabolic steroids.

Authors:  Serena Cocca; Massimo Viviano
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2017-02-20

10.  Identification of black market products and potential doping agents in Germany 2010-2013.

Authors:  Oliver Krug; Andreas Thomas; Katja Walpurgis; Thomas Piper; Gerd Sigmund; Wilhelm Schänzer; Tim Laussmann; Mario Thevis
Journal:  Eur J Clin Pharmacol       Date:  2014-08-30       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.